Phenominer Database Results (50 results)

 

How to display a graph
Strain Phenotype Conditions Study Experiment Name Sex Age # of Animals Average Type Value Units SEM SD Method Method Site Method Duration Post Insult Time Value Method Notes Clinical Measurement Notes Record ID Study ID
BB.SHR-(D6Rat184-D6Rat3)/K serum total cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood cholesterol amount male 84 days 22 88.8 mg/dl 1.89 8.88 automated blood analysis opthalmic venous plexus 0 12982 324
BB.SHR-(D6Rat184-D6Rat3)/K serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood triglyceride amount male 84 days 17 132.74 mg/dl 9.01 37.17 automated blood analysis opthalmic venous plexus 0.0 0 70105 324
BB.SHR-(D6Rat184-D6Rat3)/K blood glucose level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood glucose amount both 84 days 32 105.0 mg/dl 1.77 10.0 automated blood analysis opthalmic venous plexus 0.0 0 70110 324
BB.SHR-(D6Rat184-D6Rat3)/K percentage of study population developing diabetes mellitus during a period of time control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait female 210 days 69 86.0 % manually read urine glucose test strip 0.0 0 70113 324
BB.SHR-(D6Rat184-D6Rat3)/K age at onset/diagnosis of diabetes mellitus control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait male 210 days 49 103.0 d 5.14 36.0 manually read urine glucose test strip 0.0 0 70118 324
BB.SHR-(D6Rat184-D6Rat3)/K blood B lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. B cell quantity both 90 days 30 37.7 % 2.03 11.1 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75598 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 0.05 % 0.01 0.02 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84689 324
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 46 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 12981 324
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass female 84 days 15 214.0 g 3.36 13.0 body weighing method 0.0 0 66145 324
BB.SHR-(D6Rat184-D6Rat3)/K systolic blood pressure control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. arterial blood pressure trait both 84 days-98 days 32 serial mean 119.0 mmHg 1.41 8.0 tail cuff volume pressure recording tail 0.0 0 average of 3 measurements, on 3 different days 66146 324
BB.SHR-(D6Rat184-D6Rat3)/K blood glucose level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood glucose amount both 84 days 46 106.0 mg/dl 2.36 16.0 automated blood analysis opthalmic venous plexus 0.0 0 12979 324
BB.SHR-(D6Rat184-D6Rat3)/K serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood triglyceride amount female 84 days 24 106.2 mg/dl 9.57 46.9 automated blood analysis opthalmic venous plexus 0 12988 324
BB.SHR-(D6Rat184-D6Rat3)/K age at onset/diagnosis of diabetes mellitus control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait male 210 days 43 136.0 d 1.98 13.0 manually read urine glucose test strip 0.0 0 70120 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 64.6 % 1.61 8.8 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84685 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD4 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 37.8 % 2.15 11.8 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84625 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD25 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 30 65.6 % 3.36 18.4 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84637 324
BB.SHR-(D6Rat184-D6Rat3)/K blood lymphocyte count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 10 1.87 x 1000 cells/ul 0.19 0.6 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75596 324
BB.SHR-(D6Rat184-D6Rat3)/K blood B lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. B cell quantity both 90 days 10 31.0 % 1.9 6.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75599 324
BB.SHR-(D6Rat184-D6Rat3)/K serum total cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood cholesterol amount female 84 days 24 104.25 mg/dl 1.34 6.56 automated blood analysis opthalmic venous plexus 0 12983 324
BB.SHR-(D6Rat184-D6Rat3)/K serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood triglyceride amount male 84 days 22 141.59 mg/dl 13.4 62.83 automated blood analysis opthalmic venous plexus 0 12986 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(low) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 70.9 % 1.93 6.1 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84686 324
BB.SHR-(D6Rat184-D6Rat3)/K percentage of study population developing diabetes mellitus during a period of time control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait male 210 days 49 86.0 % manually read urine glucose test strip 0.0 0 70112 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD8 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD8-positive T cell quantity both 90 days 30 0.7 % 0.13 0.7 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84628 324
BB.SHR-(D6Rat184-D6Rat3)/K blood natural killer cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. natural killer cell quantity both 90 days 10 14.7 % 0.7 2.2 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84632 324
BB.SHR-(D6Rat184-D6Rat3)/K blood T lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 30 11.0 % 0.82 4.5 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75601 324
BB.SHR-(D6Rat184-D6Rat3)/K blood T lymphocyte count to total leukocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 10 10.4 % 0.95 3.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75602 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 4.6 % 0.53 2.9 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84682 324
BB.SHR-(D6Rat184-D6Rat3)/K white blood cell count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. leukocyte quantity both 90 days 30 3.77 x 1000 cells/ul 214.34 1174.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75604 324
BB.SHR-(D6Rat184-D6Rat3)/K serum total cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood cholesterol amount female 84 days 15 123.55 mg/dl 2.29 8.88 automated blood analysis opthalmic venous plexus 0.0 0 70102 324
BB.SHR-(D6Rat184-D6Rat3)/K percentage of study population developing diabetes mellitus during a period of time control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait male 210 days 43 14.0 % manually read urine glucose test strip 0.0 0 70114 324
BB.SHR-(D6Rat184-D6Rat3)/K white blood cell count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. leukocyte quantity both 90 days 10 2.98 x 1000 cells/ul 0.28 0.87 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75605 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD8 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD8-positive T cell quantity both 90 days 10 0.8 % 0.09 0.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84629 324
BB.SHR-(D6Rat184-D6Rat3)/K blood natural killer cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. natural killer cell quantity both 90 days 30 13.3 % 1.15 6.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84631 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD25 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 10 36.6 % 2.18 6.9 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84638 324
BB.SHR-(D6Rat184-D6Rat3)/K blood lymphocyte count control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. lymphocyte quantity both 90 days 30 2.02 x 1000 cells/ul 0.15 0.82 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 75595 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T cell count to CD45RC(low) CD4 T cell count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 30 0.08 % 0.01 0.05 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84688 324
BB.SHR-(D6Rat184-D6Rat3)/K blood RT6.1 positive cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 30 3.0 % 0.6 3.3 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84634 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD4 lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 43.3 % 1.9 6.0 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84626 324
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass male 84 days 17 324.0 g 6.79 28.0 body weighing method 0.0 0 66144 324
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass female 84 days 24 200.0 g 3.06 15.0 body weighing method 0.0 0 12976 324
BB.SHR-(D6Rat184-D6Rat3)/K percentage of study population developing diabetes mellitus during a period of time control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait female 210 days 45 13.0 % manually read urine glucose test strip 0.0 0 70115 324
BB.SHR-(D6Rat184-D6Rat3)/K age at onset/diagnosis of diabetes mellitus control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait female 210 days 69 104.0 d 3.13 26.0 manually read urine glucose test strip 0.0 0 70119 324
BB.SHR-(D6Rat184-D6Rat3)/K age at onset/diagnosis of diabetes mellitus control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. glucose metabolism trait female 210 days 45 138.0 d 2.24 15.0 manually read urine glucose test strip 0.0 0 70121 324
BB.SHR-(D6Rat184-D6Rat3)/K serum insulin level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood insulin amount both 84 days 32 0.0 mg/dl 0.0 0.0 enzyme linked immunosorbent assay opthalmic venous plexus 0.0 0 ng/ml is unit 70099 324
BB.SHR-(D6Rat184-D6Rat3)/K blood RT6.1 positive cell count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. T cell quantity both 90 days 10 1.7 % 0.13 0.4 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84635 324
BB.SHR-(D6Rat184-D6Rat3)/K blood CD45RC(high) CD4 T lymphocyte count to total lymphocyte count ratio control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. CD4-positive T cell quantity both 90 days 10 3.2 % 0.38 1.2 fluorescence-activated cell sorting method opthalmic venous plexus 0.0 0 84683 324
BB.SHR-(D6Rat184-D6Rat3)/K body weight control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. body mass male 84 days 22 302.0 g 4.9 23.0 body weighing method 0.0 0 12975 324
BB.SHR-(D6Rat184-D6Rat3)/K systolic blood pressure control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. arterial blood pressure trait both 84 days-98 days 46 serial mean 120.0 mmHg 1.47 10.0 tail cuff volume pressure recording tail 0.0 0 average of 3 measurements, on 3 different days 12992 324
BB.SHR-(D6Rat184-D6Rat3)/K serum triglyceride level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood triglyceride amount female 84 days 15 176.99 mg/dl 16.91 65.49 automated blood analysis opthalmic venous plexus 0.0 0 70106 324
BB.SHR-(D6Rat184-D6Rat3)/K serum total cholesterol level control condition Kloting I, et al., Biochem Biophys Res Commun 2001 May 4;283(2):399-405. blood cholesterol amount male 84 days 17 127.41 mg/dl 2.53 10.42 automated blood analysis opthalmic venous plexus 0.0 0 70101 324